Evaluation of the Effect of Melissa officinalis L. on Cognitive Impairments in major Depressive Disorder Patients Treated with Electroshock Therapy: A Randomized Clinical Trial
Randomized clinical trial reveals no significant improvement in cognitive impairments in major depressive disorder patients after ECT with Melissa officinalis therapy.
Key Points
No significant improvement in cognitive impairments was observed among patients after treatment with M. officinalis.
MMSE scores showed no statistically significant difference before or after the intervention in both groups.
This randomized clinical trial involved 70 patients treated with either M. officinalis or placebo over their ECT course.
Findings suggest that more extended treatment periods with M. officinalis should be explored for cognitive impairments.